Skip to main content
BELLUSCURA PLC logo

BELLUSCURA PLC — Investor Relations & Filings

Ticker · BELL ISIN · GB00BD3B8Z11 LEI · 213800BRJQZE56XBPW94 IL Manufacturing
Open in API
Filings indexed 240 across all filing types
Latest filing 2023-10-17 Regulatory Filings
Country GB United Kingdom
Listing IL BELL

About BELLUSCURA PLC

https://belluscura.com/

Belluscura PLC is a medical device company specializing in the development and commercialization of advanced oxygen enrichment technologies. The company's primary focus is on manufacturing lightweight, portable oxygen concentrators (POCs) designed to improve the quality of life for individuals requiring supplemental oxygen therapy. Its product portfolio is headlined by the FDA-cleared X-PLOR® and the DISCOV-R™ models. These devices utilize proprietary, patented technologies such as ModulAir™ and an Airgonomical™ design to deliver high oxygen output in a compact form factor, offering an alternative to traditional, cumbersome oxygen tanks and promoting user mobility and independence.

Recent filings

Filing Released Lang Actions
Form 8.3 - Belluscura plc - Replacement
Regulatory Filings Classification · 95% confidence The document is explicitly titled 'FORM 8.3' and references 'Rule 8.3 of the Takeover Code'. This form is a 'PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE'. This type of disclosure relates to insider transactions or significant ownership changes during a takeover or potential takeover scenario. While it involves director/insider activity (related to DIRS), its primary context is regulatory disclosure concerning a potential takeover bid (related to TAR). However, the specific nature of this filing (Form 8.3 under the Takeover Code) is a specialized regulatory filing concerning interests in securities during an offer period. Since there is no specific code for 'Takeover Disclosure Form 8.3', and it is a mandatory regulatory filing disseminated via RNS, it fits best under the general 'Regulatory Filings' (RNS) category, as it is not a standard DIRS report (which usually refers to routine insider trading reports outside of a formal offer period) nor a M&A Activity (TAR) announcement itself, but rather the required disclosure *during* such activity. Given the options, RNS is the most appropriate general regulatory fallback for this specific form type.
2023-10-17 English
Form 8.3 - Belluscura plc
Director's Dealing Classification · 95% confidence The document is explicitly titled 'FORM 8.3' and references 'Rule 8.3 of the Takeover Code'. This form is used for 'PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE' concerning an offeror/offeree (Belluscura plc). This type of disclosure relates to insider dealings or significant ownership changes during a takeover or similar corporate action. While it involves director/insider activity (similar to DIRS), the specific context of the Takeover Code disclosure (Form 8.3) is best categorized under general regulatory filings related to market activity, which aligns most closely with the 'Director's Dealing' (DIRS) definition if we consider the nature of the disclosure, or the general 'Regulatory Filings' (RNS) as a fallback. However, since it specifically details personal share transactions/interests of an individual connected to an offer, DIRS is a strong candidate, but DIRS is defined as 'Report of personal share transactions by company directors and executives (insider trades)'. Form 8.3 is a mandatory disclosure under the Takeover Code, which is a specific regulatory requirement. Given the options, and recognizing that this is a mandatory disclosure about ownership/dealing related to a potential corporate action, it is a specific type of insider/director dealing disclosure. If we strictly follow the definitions, DIRS covers personal share transactions by directors/executives. Form 8.3 is a specific regulatory filing about interests/dealings during an offer period. Since the document is a formal regulatory filing (RNS Number 4219Q, referencing the Takeover Code) detailing ownership and dealings, and it is not a general earnings release, annual report, or proxy statement, it falls under the umbrella of regulatory disclosures. Given the specific nature of reporting personal transactions/interests, DIRS is the most relevant specific category, although RNS is the general regulatory filing category. Since the content is entirely about the discloser's position and dealings, DIRS is chosen over the generic RNS.
2023-10-17 English
Form 8.3 - Belluscura plc
Director's Dealing Classification · 98% confidence The document is explicitly titled 'FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE' and references 'Rule 8.3 of the Takeover Code'. This form is used to disclose insider dealings or significant ownership changes related to a takeover offer. This specific type of disclosure, concerning director/insider transactions, aligns most closely with the 'Director's Dealing' category (DIRS). Although it is a regulatory filing, DIRS is more specific than the general RNS fallback.
2023-10-17 English
Form 8.3 - Belluscura plc
Director's Dealing Classification · 95% confidence The document is explicitly titled 'FORM 8.3' and references 'Rule 8.3 of the Takeover Code'. This form is used for 'PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE' in relation to an offer (Takeover/M&A activity). While it relates to a takeover, the specific filing type for director/insider dealing is DIRS, but this form (Form 8.3) is a specific regulatory disclosure mandated by the Takeover Code, which often falls under general regulatory announcements or specific insider dealing rules. Since the core content is about an individual's position and dealings in securities related to an offer, it strongly aligns with insider trading/director dealing disclosures. However, Form 8.3 is a specific disclosure required during a takeover period. Given the options, 'Director's Dealing' (DIRS) is the closest fit for reporting personal security interests/transactions by an individual connected to a company involved in an event (here, a potential takeover). If DIRS is too narrow, RNS (Regulatory Filings) is the fallback. Since it details ownership and dealings of an individual (Elie Basil Victor Dangoor) in the securities of the offeree (Belluscura plc) under the Takeover Code, DIRS is the most precise category for insider transaction reporting, even if the context is a takeover.
2023-10-17 English
Form 8.3 - Belluscura Plc
Director's Dealing Classification · 95% confidence The document is explicitly titled 'FORM 8.3' and references 'Rule 8.3 of the Takeover Code'. This form is a 'PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE'. This type of disclosure relates to insider/significant shareholder dealings, often in the context of a takeover offer. The closest matching category among the provided definitions is 'Director's Dealing' (DIRS), as it covers personal share transactions by executives/insiders, although Form 8.3 is specifically mandated by the Takeover Code. Since DIRS covers insider trades, it is the most appropriate fit over the general 'Regulatory Filings' (RNS). The document is a specific regulatory disclosure, not a general announcement of a report.
2023-10-16 English
Form 8.3 - Belluscura plc
Regulatory Filings Classification · 98% confidence The document is explicitly titled 'FORM 8.3' and references 'Rule 8.3 of the Takeover Code'. This form is used for 'PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE' in the context of a takeover offer (Belluscura plc). This type of disclosure, mandated by the UK Takeover Panel, is a specific regulatory filing related to insider/major shareholder activity during a takeover scenario. While it relates to director/insider dealings (DIRS), the specific context of a Form 8.3 under the Takeover Code makes it a highly specific regulatory disclosure. Since there is no specific code for 'Takeover Disclosure Form 8.3', and it is a mandatory regulatory filing disseminated via RNS, it falls best under the general 'Regulatory Filings' (RNS) category, as it is not a standard DIRS report (which usually refers to Form 3, 4, or 5 equivalent filings outside of takeover contexts) and is not a general financial report.
2023-10-16 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.